Gold/lanthanide nanoparticle conjugates and uses thereof

US8968705B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8968705-B2
Application numberUS-201013202311-A
CountryUS
Kind codeB2
Filing dateFeb 17, 2010
Priority dateAug 22, 2008
Publication dateMar 3, 2015
Grant dateMar 3, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.

First claim

Opening claim text (preview).

We claim: 1. A gold/lanthanide nanoparticle conjugate comprising: a gold nanoparticle; a lanthanide containing metal organic framework disposed on said gold nanoparticle; and a polymer, polymer precursor, or initiator grafted directly onto said lanthanide containing metal organic framework. 2. The nanoparticle conjugate according to claim 1 , wherein the polymer, polymer precursor or initiator is grafted onto the lanthanide containing metal organic frame…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8968705B2 cover?
The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
Who is the assignee on this patent?
Boyes Stephen G, Rowe Misty D, Colorado School Of Mines
What technology area does this patent fall under?
Primary CPC classification A61K49/1878. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).